Hemiplegia — Clinical Documentation Guide (2026)

🔍 Definition

Hemiplegia is paralysis (complete loss of voluntary motor function) affecting one side of the body — the arm, leg, and often the face on the same side. The term hemiparesis refers to weakness rather than complete paralysis; however, per ICD-10-CM Official Guidelines, both hemiplegia and hemiparesis are captured under the same G81 category — the distinction between complete paralysis and weakness does not change code assignment.

The lesion responsible for hemiplegia is typically located in the contralateral cerebral hemisphere (motor cortex or internal capsule), the ipsilateral brainstem, or the cervical spinal cord. The etiology drives both clinical management and ICD-10-CM code selection: post-stroke sequelae (I69.xx), traumatic brain injury sequelae (S06.x with 7th character S), primary structural lesions, or other neurological diseases each map to different code families.

Accurate documentation must capture: (1) laterality — which side of the body is affected; (2) dominance — whether the affected side is the patient's dominant or nondominant side; (3) type — flaccid vs. spastic; and (4) cause — this determines whether the principal sequela code family is G81.xx, I69.xx, or another category. According to CMS FY2026 ICD-10-CM Official Coding Guidelines, if documentation does not specify dominance, right-sided hemiplegia is coded as dominant and left-sided as nondominant; for ambidextrous patients, either side is coded dominant.

🗂️ Alternative Terminology

🩺 Signs & Symptoms

Hemiplegia presents with a constellation of motor and associated neurological findings depending on the level and cause of the lesion:

• Motor: Paralysis or significant weakness of the arm, hand, leg, and lower face on one side. In spastic hemiplegia, increased tone (hypertonia), brisk deep tendon reflexes, and Babinski sign (extensor plantar response) are characteristic. In flaccid hemiplegia (often acute phase or lower motor neuron origin), tone is reduced and reflexes are diminished.
• Gait: Circumduction gait (spastic leg swings outward), scissor gait in bilateral spastic involvement, or steppage gait with foot drop.
• Upper extremity posturing: Shoulder adduction, elbow flexion, wrist/finger flexion (hemiplegic posture).
• Spasticity: Velocity-dependent increase in muscle tone, often measured by the Modified Ashworth Scale (MAS 0–4) or Tardieu Scale. Spasticity impairs ADLs, causes pain, and is a major rehabilitation target.
• Dysphagia: Present in up to 50% of post-stroke hemiplegia; coded separately (I69.391 dysphagia following cerebral infarction, or R13.1x if acute).
• Aphasia / dysphasia: When dominant hemisphere is affected; coded separately (I69.320 aphasia following cerebral infarction).
• Hemianopia: Visual field loss on the hemiplegic side.
• Sensory loss: Hemisensory deficits (pain, temperature, proprioception) contralateral to the lesion.
• Cognitive / behavioral: Hemispatial neglect, depression, pseudobulbar affect.
• Bowel and bladder dysfunction: Neurogenic bladder, incontinence.
• Shoulder pain: Subluxation of the hemiplegic shoulder is common, causing chronic pain.

🧭 Differential Diagnosis

📋 Clinical Indicators for Coders/CDI

🦴 Anatomy & Pathophysiology

The primary motor cortex (Brodmann area 4) in the precentral gyrus of the frontal lobe controls voluntary motor function via the corticospinal (pyramidal) tract. Upper motor neuron (UMN) axons descend ipsilaterally through the corona radiata → internal capsule (posterior limb) → cerebral peduncles → brainstem → decussate at the pyramidal decussation in the medulla → descend as the lateral corticospinal tract in the contralateral spinal cord → synapse on lower motor neurons (LMN) in the anterior horn.

A unilateral lesion anywhere along this pathway before the decussation causes contralateral hemiplegia; a lesion below the decussation (e.g., cervical cord hemicord lesion) causes ipsilateral hemiplegia.

Flaccid vs. Spastic Phases

• Flaccid (acute/shock) phase: Immediately after UMN injury, the spinal cord below the lesion enters a state of "spinal shock" — reflexes are absent, tone is reduced, paralysis is flaccid. This may persist days to weeks. Coded as G81.0x.
• Spastic (chronic) phase: As spinal cord circuits reorganize (weeks to months after UMN injury), hyperreflexia, clonus, increased tone, and spasticity emerge due to loss of inhibitory corticospinal control. Coded as G81.1x. Spasticity driven by alpha motor neuron disinhibition is the target of baclofen, botulinum toxin, and physical therapy.

Common Etiologies and Lesion Locations

• Ischemic stroke: Middle cerebral artery (MCA) occlusion → contralateral face + arm > leg hemiplegia; internal capsule lacunar infarct → pure motor hemiplegia.
• Hemorrhagic stroke: Hypertensive hemorrhage most often in putamen/internal capsule.
• TBI: Diffuse axonal injury or focal contusion in motor areas.
• Demyelination (MS): Plaque in corticospinal tract.
• Brainstem lesion: Produces crossed (alternating) hemiplegia — ipsilateral cranial nerve palsy + contralateral hemiplegia.
• Spinal cord — Brown-Séquard (G83.81): Hemisection → ipsilateral UMN paralysis + ipsilateral proprioception loss + contralateral pain/temperature loss.

💊 Medication Impact / Treatment

Spasticity Management

• Baclofen (oral): GABA-B agonist; first-line for spasticity. Intrathecal baclofen pump (ITB) indicated for severe spasticity unresponsive to oral therapy — 62361–62370 for pump implantation/revision/refill + J0475/J0476 for intrathecal baclofen drug.
• Botulinum toxin type A (onabotulinum toxin A): Chemodenervation of spastic extremity muscles. CPT 64615 (chemodenervation of muscle — upper limb, trunk, or head/neck) or 64616 (lower extremity). Drug code J0585 (onabotulinumtoxinA, per unit). Dosing typically 100–400 units per session; repeat every 12–16 weeks. MAS ≥2 supports medical necessity.
• Tizanidine, cyclobenzaprine, dantrolene: Alternative oral antispastics. Dantrolene acts peripherally at muscle level (ryanodine receptor).
• Diazepam: GABA-A agonist; used cautiously due to sedation and dependence risk.

Stroke Secondary Prevention (affects comorbidity coding)

• Antiplatelet therapy (aspirin, clopidogrel) for ischemic stroke — Z79.82
• Anticoagulation (warfarin Z79.01, DOAC Z79.01) for AF-related stroke
• Statins — Z79.899
• Antihypertensives — hypertension I10 should always be coded with stroke sequela

Neuroprotective and Emerging Therapies

Constraint-induced movement therapy (CIMT) restricts the unaffected limb to force use of the hemiplegic limb — coded via CPT 97530 therapeutic activities. Transcranial magnetic stimulation (TMS) and brain–computer interfaces are investigational. Functional electrical stimulation (FES) for foot drop.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides